6-145805297-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_032145.5(FBXO30):āc.1109T>Cā(p.Val370Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,614,100 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_032145.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO30 | NM_032145.5 | c.1109T>C | p.Val370Ala | missense_variant | 2/3 | ENST00000237281.5 | NP_115521.3 | |
FBXO30 | NM_001348092.2 | c.1109T>C | p.Val370Ala | missense_variant | 2/3 | NP_001335021.1 | ||
FBXO30 | XM_047419398.1 | c.1217T>C | p.Val406Ala | missense_variant | 2/3 | XP_047275354.1 | ||
EPM2A-DT | NR_038246.1 | n.53-23064A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO30 | ENST00000237281.5 | c.1109T>C | p.Val370Ala | missense_variant | 2/3 | 1 | NM_032145.5 | ENSP00000237281.3 | ||
EPM2A-DT | ENST00000629681.1 | n.91-4481A>G | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152232Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251168Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135754
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461750Hom.: 0 Cov.: 34 AF XY: 0.00000550 AC XY: 4AN XY: 727184
GnomAD4 genome AF: 0.000125 AC: 19AN: 152350Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74508
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 20, 2024 | The c.1109T>C (p.V370A) alteration is located in exon 2 (coding exon 1) of the FBXO30 gene. This alteration results from a T to C substitution at nucleotide position 1109, causing the valine (V) at amino acid position 370 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at